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Abstract: 
Traumatic brain injury (TBI) is the most prevalent health problem affecting all age groups, and 
leads to many secondary problems in the other organs especially kidneys, gastrointestinal tract 
and heart function. In this review, the search terms were traumatic brain injury (TBI), fluid 
percussion injury (FPI), cold injury (CI), weight drop–impact acceleration injury (WDIAI), 
lateral fluid percussion (LFP), ortical impact injury (CCI) and blast injury. Studies with Actaea 
racemosa, Artemisia annua, Aframomum melegueta, Carthamus tinctorius, Cinnamomum 
zeylanicum, Crocus sativus, Cnidium monnieri, Curcuma longa, Gastrodia elata, Malva 
sylvestris, Da Chuanxiong Formula, Erigeron breviscapus, Panax ginseng, Salvia tomentosa, 
Satureja khuzistanica, Nigella sativa, Drynaria fortune, Dracaena cochinchinensis, Polygoni 
Cuspidati, Rosmarinus ofﬁcinalis, Rheum tanguticum, Centella asiatica and Curcuma zedoaria,  
show significant decrease in neuronal injury by different mechanisms such as increasing 
superoxide dismutase (SOD) and catalase (CAT) activities, suppressing nuclear factor kappa B 
(NF-κB), IL-1, glial fibrillary acidic protein (GFAP) and IL-6 expression.  The aim of this study 
was to evaluate the neuroprotective effects of medicinal plants in central nervous system (CNS) 
pathologies by reviewing the available literature. 
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1. Introduction 
One of the major cause of morbidity and mortality in both developed and developing countries is 
traumatic brain injury (TBI) especially people under the age of 45 years. TBI attributes to 
approximately 10 million deaths and/or hospitalizations annually. Biomechanical and 
neurochemical damage following TBI, usually leads to a deficit in behavioral, cognitive, 
neuropsychiatric, and physical functions (1, 2). 
Systemic insults of TBI include both hypoxia and hypotension mechanistically.   In addition, 
acute cell death and delayed apoptosis have a relative contribution. Mechanisms of cell damage 
in TBI include free radical production, excitotoxicity, oxidative stress, inflammation and 
apoptosis. Genetic factors are also associated to the pathophysiology of TBI.   In addition, 
myelin and multifocal axonal abnormalities are also attributed to posttraumatic cognitive 
impairments (3-6). 
Various aspects of human TBI have been studied in a variety of animal models over the decades 
to have a better better understanding of the pathophysiology and potential treatments. These 
models of TBI include cortical impact injury (CCI), fluid percussion injury (FPI), blast injury 
and weight drop–impact acceleration injury (Table 1), (7). 
Various traditional supplements and herbal medicine therapies for TBI have been developed 
recently. These include both crude extracts and isolated compounds from plants and has shown 
to have neuroprotective effects due to their antioxidant and anti-inflammatory action on nerve 
function. The medicinal plants included in this review are Aframomum  melegueta, Carthamus 
tinctorius, Cinnamomum zeylanicum, Crocus sativus, Da Chuanxiong Formula, Erigeron 
breviscapus, Panax ginseng, Salvia tomentosa, Nigella sativa, Dracaena cochinchinensis, 
Polygoni Cuspidati, Rosmarinus ofﬁcinalis, Centella asiatica, Curcuma zedoaria. To date, there 
are no reviews about the neuroprotective function of medicinal plants in TBI.  In view of 
increasing number of studies conducted in the recent years, we reviewed the literature to assess 
the potential neuroprotective role of herbal plants in TBI including active components, 
experimental methodologies and mechanisms of action. 
2. Method 
Online literature resources were searched using search engines such as ISI Web of Knowledge, 
Pub Med, Medline, Scopus and Google Scholar from 1976 to August 2018 to identify studies, 
editorials, and reviews about the effect of medicinal plants on TBI and their possible 
mechanisms. We used appropriate keywords such as traumatic brain injury (TBI), medicinal 
plants, fluid percussion injury (FPI), cold injury (CI), cortical impact injury (CCI), lateral fluid 
percussion (LFP), weight drop–impact acceleration injury (WDIAI), and blast injury. All of 
these keywords were searched for each of these plants and its constituents. 
3. Results 
3.1.  Actaea racemosa 
Actaea racemosa (A. racemosa) commonly called black cohosh, is a perennial rhizomatous 
forest herb with white to yellow ﬂowers, belonging to the Ranunculaceae. The chemical 
constituents of A. racemosa are caffeic acid, ferulic acid, phenylpropanoids, triterpenoids, 
cimigenol and formononetin (8). This plant has been shown to have several therapeutic effects 
including anti-inﬂammatory (9), antioxidant (10), antidepressant (11) and immunomodulatory 
(12)  effects. 
The effect of formononetin orally was evaluated for 7 days after the induction TBI by WDIAI 
model in rat. There was a significant improvement in neurological severity score (NSS) and 
increased cortical neuronal numbers in Nissl-special and DAPI-labeled stains with formononetin. 
Formononetin also reduced the levels of IL-6 and TNF-alpha and increased the IL-10 levels in 
serum and cerebral cortex (13). In another study, intra-pertonieal injection of formononetin for 5 
days after the induction TBI by WDIAI model in rat showed formononetin improved NSS, 
reduced brain edema and inhibited the neuronal apoptosis. Additionally, formononetin up-
regulated the expression of microRNA-155 (miR-155) and haeme oxygenase 1 (HO-1) and 
down-regulated the expression of BACH1 in the brain tissue of TBI rats (14). 
3.2.  Aframomum  melegueta 
Aframomum melegueta (A. melegueta), commonly known as grains of paradise, ossame, alligator 
pepper, Melegueta pepper, fom wisa, Guinea grains, or Guinea pepper, is a ﬂowering plant 
belonging to the family Zingiberaceae. It has been used traditionally in African folk medicine to 
treat several conditions including stomach ache, diarrhea, hypertension and is also used as a 
purgative, galactogogue, anthelmintic, and hemostatic agent (15). The main components of this 
plant include cardiac glycosides, alkaloids, sterols,  tannins, triterpenes, flavonoids,  and oils 
(16). This plant also has various pharmacological effects including antimicrobial (17), anti-ulcer 
and cytoprotective (18), antioxidant (19), antidiabetic (20), antifungal (21) and antihypertensive 
(22) activities actions. 
A. melegueta seeds possess significant anti-inflammatory and anti-nociception activity. The anti-
nociceptive activity of this plant has been investigated using the Randall–Selitto paw pressure, 
formalin-induced paw edema, and hot plate models of nociception. This plant extract showed 
anti-inflammatory effect with the formalin test, and reduced response to nociceptive stimuli 
evoked by squeezing of the inflamed hind paw of rats (23). A. melegueta seeds’ ethanolic extract 
and pure compounds of its including [6]-paradol, [6]-shogaol, [6]-gingerol have been studied in 
vitro on pro-inflammatory gene expression and inflammatory enzymes such as lipoxygenases 
(LOX) and cyclooxygenase-2 (COX-2) and they are found to have an anti-inflammatory effect 
(24). Aqueous seed extract of A. melegueta (50–200 mg/kg, i.p.) have been investigated in vivo 
by formaldehyde and nystatin induced sub–chronic inflammatory conditions in rats and is found 
to have an anti-inflammatory effect (25). 
The effect of hydroethanolic extract of A. melegueta seed on male rat was evaluated in FPI 
model of TBI. Eleven days after injury, rats were sacrificed and their brains were collected for 
assessment of microglial activation. Immunohistochemical analysis of injured rat brain sections 
using an antibody to CD11b (a marker of activated microglia) showed that this extract reduced 
microglial activation in the rat cortex and hippocampus. It also showed that the administration of 
A. melegueta extract after injury reduced the number of Fluoro-Jade (a marker for neuronal 
injury) positive neurons in the CA1/2 and CA3 regions on the hippocampus of ipsilateral side 
(26).  
3.3.Allium sativum 
Allium sativum (A. sativum) or garlic, is a bulbous plant belonging to the Amaryllidaceae family. 
In Ayurvedic medicine, this is used to treat respiratory conditions, dyspepsia, colic and flatulence 
(27). This plant is also shown to have anti-nociceptive (28), anticonvulsant (29), anti-
inflammatory, immunomodulatory (30) and antioxidant (31) properties.  
The effect of allicin (an organosulfur compound obtained from garlic), on CCI model of TBI 
showed that allicin reduced contusion volume and water content of brain, neurological deficit 
scores, Bcl-2/Bax ratio, MDA, protein carbonyl, TNF-α and IL-1β levels. It increased the 
activities of CAT, SOD and GST levels of IL-10 and transforming growth factor beta 1 (TGF-
β1). It also activated Akt and endothelial nitric oxide synthase (eNOS) as well as inhibited the 
activation of caspase-3 and PARP (32).  
3.4.Artemisia annua 
Artemisia annua (A. annua), or sweet wormwood, is an annual, aromatic herb, belonging to the 
Asteraceae and has been used in China to treat fevers for centuries (33). It is often used in the 
Tropics as an affordable and effective anti-malarial (34). Leaves of A. annua has been used as 
antiseptic, digestive and febrifuge (35, 36). A leaf infusion of this plant is used as a remedy for 
colds, fevers and diarrhea (35, 37). The main ingredients of the essential oil of A. annua are ß-
pinene, alpha-pinene, camphor, camphene, 1,8-cineole, artemisia ketone, myrcene, borneol, 
linalool and ß-caryophyllene (38). The pharmacological effects of A. annua include its anti-
malarial (39), antioxidant, anti-inflammatory, antimicrobial (40), immunomodulatory (41) and 
anti-cancer properties (42). A variety of compounds have been isolated from A. annua such as 
coumarins, flavonoids, sesquiterpenoids, triterpenoids, phenolics,  and artemisinin (43). 
The effect of atesunate,  a more stable derivative of its precursor artemisin, on CCI model of TBI 
showed that atesunate reduced tissue damage and inﬂammation in histological studies. 
Additionally, it reduced the expression of brain-derived neurotrophic factor (BDNF), vascular 
endothelial growth factor (VEGF), glial cell line-derived neurotrophic factor (GDNF) and 
inﬂammasomes components (NLRP3, ASC and Caspase-1) as well as Il-1ß, TNF-α and iNOS 
levels (44). 
3.5.Carthamus tinctorius 
Carthamus tinctorius (C. tinctorius), also known as Safflower, is s thistle-like annual plant with 
yellow, orange, or red ﬂowers, belonging to the Compositae or Asteraceae family, cultivated 
mainly for its seed, which is used as edible oil and as birdseed. Traditionally, the crop was grown 
for its flowers, used for colouring and flavouring foods and making dyes, and in medicines (45). 
Several pharmacological effects have been described for C. tinctorius such as its anti-
inﬂammatory (46), cardioprotective (47), antioxidant and neuroprotective (48) and anticancer 
(49). The standardized safflower flavonoid extract (SAFE), (35 and 70 mg/kg, p.o.) and the 
compounds isolated from safflower including kaempferol 3-O-rutinoside (K3R), anhydrosafflor 
yellow B (AYB), (50, 100 and 200 μM) were evaluated for their neuroprotective effects in vitro 
and in vivo using PD models employing 6-hydroxydopamine (6-OHDA)-lesioning in rats and 
rotenone-induced damage to differentiated PC12 cells, respectively. The results showed that 
K3R and AYB inhibited microtubule destabilization and decreased cell area and SAFE improved 
behavioural performances, partially via the suppression of α-synuclein overexpression or 
aggregation, as well as the suppression of reactive astrogliosis (50). However, some studies were 
reported the toxic effect of C. tinctorius on renal and brain tissue (51). C. tinctorius extract  has 
been shown to reduce the cerebral infarction area and neurological deficits as well as expression 
of TNF-α and IL-1β in ischemia–reperfusion (I/R) brain injury in rats (52).  
The effect of hydroxysafflor yellow A (HSYA), a constituent of the flower petals of Carthamus 
tinctorius, on CCI model of TBI showed that HSYA increased the activities of superoxide 
dismutase (SOD) and catalase (CAT), the level of glutathione (GSH) and the GSH/glutathione 
disulfide (GSSG) ratio and decreased the levels of malondialdehyde (MDA) and GSSG (53). 
3.6. Cinnamomum zeylanicum 
Cinnamomum zeylanicum (C. zeylanicum) is commonly known as cinnamon, from the Lauraceae 
family. The major components of the essential oil of C. zeylanicum are trans-cinnamaldehyde, 
eugenol, linalool (54). C. zeylanicum is used as part of Ayurvedic medicine as a remedy for a 
variety of digestive, respiratory and gynaecological symptoms (55). Various pharmacological 
effects of  cinnamon have been reported including antibacterial (56), antifungal (57), antioxidant 
(58), anti-diabetic (59), anti-inﬂammatory (60) and immunomodulatory (61) effects When 
administered orally in experimental allergic encephalomyelitis in mice, cinnamon powder 
suppressed the expression of iNOS and IL-1ß in vivo in the spinal cord and cerebellum 
suggesting anti-inflammatory effects (62). In addition, cinnamon suppressed neuronal apoptosis, 
inhibition of glial activation, and reduced amyloid beta in the hippocampus and protected 
memory as well as learning in an animal model of Alzheimer’s disease (63). In an animal model 
of Parkinson’s disease, it also protected the nigrostriatum, normalised striatal neurotransmitters, 
and improved motor functions (64). 
Effect cinnamon polyphenol extract on CI model of TBI in mice showed that extract reduced 
infarct and edema formation in the brain by suppressing the expression of nuclear factor kappa B 
(NF-κB), IL-1, IL-6, glial fibrillary acidic protein (GFAP), neuronal cell adhesion molecule 
(NCAM) and nuclear factor erythroid 2-related factor 2 (Nrf2) in brain (65). 
3.7.  Cnidium monnieri 
Cnidium monnieri (C. monnieri), belongs to the Apiaceae family and is one of the most widely 
used traditional herbal medicine especially it fruits (66). The main components of C. monnieri 
are osthole, bergapten, isopimpinellin, xanthotoxol, xanthotoxin, sesquiterpenes, cnidimonal, 
cnidimarin, imperatorin and glucosides (66). The pharmacological effects of C. monnieri include 
its anticonvulsant (67), memory improvement (68), anti-inﬂammatory and immunomodulatory 
(69) activities. 
Administration of osthole a coumarin compound isolated from C. monnieri intraperitoneally, 30 
min before TBI, reduced neurological deficits, cerebral edema and hippocampal neuron loss, It 
also increased SOD activity, GSH and MDA levels, the ratio of Bcl-2/Bax, the expression of 
active caspase-3 and the number of apoptotic cells in the WDIAI induced TBI in rat (70). 
 
3.8. Crocus sativus  
Crocus sativus (C. sativus), or saffron, is a perennial stemless herb belonging to the Iridaceae 
family. The main components of C. sativus are crocin, safranal, isophorone, crocetin, 
picrocrocin, glycosidic terpenoids and ketoisophorone (71). C. sativus has also been used in 
traditional medicine for its eupeptic, antispasmodic, anti-catarrhal, gingival and nerve-sedating 
agent. It has also used as an expectorant, diaphoretic, aphrodisiac, emmenagogue and 
carminative (72). It has various pharmacological effects including anti-inflammatory, 
antioxidant, and immunomodulatory (73), anxiolytic and hypnotic (74), anticonvulsant (75) and 
anti-Alzheimer (76) activities.  
In a rat model of stroke, administration of crocin during induction of ischemia, showed 
protective effect against ischemia/reperfusion injury and cerebral edema. It also decreased brain 
edema and infarct volume (77). In addition, administration of crocin before TBI, activated the 
Notch signaling pathway by up-regulation Notch intracellular domain (NICD) and bHLH 
transcription factor 1 (HES1) mRNA. In CCI induced TBI in mice, it also reduced microglial 
activation, cell apoptosis and release of IL-1β and TNF-α as well as improved brain edema and 
neurological severity score (NSS) (78).  
3.9. Da Chuanxiong Formula 
Da Chuanxiong Formula (DCXF) in Chinese traditional medicine consists of two dried rhizomes 
of Ligusticum chuanxiong and Gastrodia elata with the ratio of 4:1 (w/w) (79). Studies have 
shown that DCXF possesses therapeutic effect on stroke, dementia, vertigo, headache and which 
is mediated by improvement of blood vessel elasticity and cerebral blood supply, reduction of 
blood brain barrier (BBB) disruption, intracellular free calcium concentration and edema 
formation. It also inhibits inﬂammation and nerve cell apoptosis (80). In LPS-incited RAW 264.7 
cells, DCXF inhibited the productions of NO and PGE2 by suppressing COX-2 and iNOS 
expressions (79). 
Treatment with DCXF aqueous extract one week before and 11 days after the induction TBI by 
CCI model in rat improved the learning ability, memory retention and proliferation of neural 
stem cells (NSCs). Results also showed that DCXF reduced astrocyte and microglia activation, 
BBB permeability, brain edema and neuronal loss in the brain with TBI (81). 
3.10. Erigeron breviscapus 
Erigeron breviscapus (E. breviscapus) known as “Dengzhanxixin”, belonging to the Asteraceae, 
is a plant species endemic to southwestern China.  It has been used in traditional Chinese 
medicine for various conditions including digestive disorders, heart disease, cerebral infarction 
and apoplexy (82). The chemical constituents of E. breviscapus are flavonoids, triterpenes, 
caffeoylic derivatives and steroids (83). It has shown to have antifungal, antimicrobial,  (84), 
antioxidant (85) and anti-inﬂammatory (86) activities. 
Injection 75 μg breviscapine (a flavonoid extracted from the E. breviscapus) via the right lateral 
ventricle after induction of TBI by CCI model remarkably improved NSS score and reduced 
expression of IL-6 in the injured cortex and IL-6-positive cell number in injured brain tissue 
(87). 
3.11.  Gastrodia elata 
Gastrodia elata (G. elata), is a saprophytic perennial herb from Orchidaceae family. The dried 
rhizome of G. elata is used as a traditional Chinese medicine for remedy neurological disorders 
such as alzheimer, general paralysis, headache, convulsions, vertigo, stroke and tetanus (88). The 
main components with neuropharmacological properties are 4-hydroxybenzaldehyde (4-HBA), 
gastrodin, vanillin, and vanillyl alcohol (89).  It has shown to have various pharmacological  
effects including antimicrobial (90), anti-mutagenic (91) anti-oxidative (92) and anti-
inﬂammatory (93) properties. 
The effects of G. elata aqueous extract on CCI model of TBI in rat showed that G. elata 
improved locomotor functions in rotarod test and reduced the number of astrocyte in 
immunohistochemical staining and the expression of IL-6 and TNF-α in the brain tissue (94). 
3.12. Malva sylvestris 
Malva sylvestris (M. sylvestris), or common mallow, belongs to the Malvaceae family.  The main 
components of M. sylvestris are polysaccharides malvin, flavonoids, scopoletin, coumarins, 
polyphenols, niacin, folic acid, tannins and vitamin A, C and E (95). M. sylvestris is used as 
bacteriostatic, anti-nociceptive anti-inflammatory, antioxidant and anticholinesterase agent in 
Chinese medicine (96). 
The preventive effect of M. sylvestris methanolic extract orally on TBI induced CCI model in rat 
showed improved cognitive function in MVM test and reduced neuronal loss and GFAP positive 
cells in hippocampus.  Additionally, it also increased levels of SOD and decreased ROS 
production as well as LPO, IL-1β, IL-6, and TNF-α levels in the brain tissue (96). 
3.13. Panax ginseng 
Panax ginseng (P. ginseng) is a perennial herb from Araliaceae family, native to Korea and 
China. Ginseng, the root of P. ginseng has been traditionally used as an herbal remedy (97). The 
main components of ginseng are ginseng oils, phytosterol, saponins, organic acids, nitrogenous 
substances, enzymes, vitamins and minerals (98). Its shown to have antimicrobial (99), 
antifungal (100), antioxidant (101), antiviral (102), anti-inﬂammatory and antifatigue (103) and 
anti-asthmatic activities (104). 
Oral administration of ginsenoside Rb1, which is the main bioactive components in ginseng 
significantly increased cell survival in the dentate gyrus (DG) and hippocampus which could be 
potentially related to its effects on memory and learning (105). In addition, ginsenoside Rg  
down regulated calpain I and caspase-3 and attenuated neuronal apoptosis induced by cerebral 
ischemia-reperfusion injury (106). 
Oral administration of P. ginseng aqueous extract on WDIAI model of TBI in rat improved 
neurological functions. In addition, P. ginseng reduced levels of MDA, nitrite, 
acetylcholinesterase (AChE), TNF-a and IL-6 and increased GSH, SOD and catalase in 
hippocampus and cerebral cortex (107) 
The major ingredient of P. ginseng, ginseng total saponins (GTS) is shown to have 
neuroprotective effects against TBI. GTS when administered intraperitoneally significantly 
reduced neuronal loss in hippocampal regions of CA1, CA2, and CA3, contusion volume and 
percentage of contusion, as well as improved neurological deficits on TBI induced CCI model in 
rat (108). 
In a similar study assess preventive effect of GTS on TBI induced CCI model in rat showed 
treatment with GTS after induction of TBI improved NSS score and reduced brain water content, 
neuronal loss in the hippocampus. It increased the activity of SOD, down-regulated IL-1β, IL-6, 
and TNF-α and upregulated IL-10. It also inhibited the apoptotic cell death and expression of 
caspase-3, bax and Bcl-2 (109). Similarly, the effect of administration of GTS on CI model of 
TBI rats was showed improved recovery of neurological functions, including learning and 
memory and reduced cell loss in the hippocampus (110). 
In another study GTS improved NSS score, increased SOD activity and reduced brain water 
content, level of MDA and expression of IL-1β and TNF-α (111). In addition, administration of 
GTS after induction of TBI improved neurological function and histological morphology of brain 
tissue in rats (112). 
3.14. Rheum tanguticum 
Rheum tanguticum (R. tanguticum), also known as rhubarb in Chinese, belongs to the 
Polygonaceae family. Traditionally, the roots and rhizomes of R. tanguticum have been used as a 
poultice for their antispasmolytic, antineoplastic, antibacterial and antipyretic properties and also 
to reduce obesity, lipid and blood pressure, (113). 
The effect of rhubarb aqueous extract (3, 6 and 12 mg/kg, p.o.) was evaluated after the induction 
of TBI by CCI model in rat. Rhubarb significantly ameliorated brain edema and BBB injury, 
increased SOD, CAT activities, GSH level and GSH/GSSG ratio. It also decreased the levels of 
MDA and GSSG. Rhubarb also prevented gp91phox subunit of NADPH oxidase activation 
induced ROS production. Additionally, it inhibited ERK/MMP-9 pathway both in vivo and in 
vitro as well as downregulated GFAP in vitro (114, 115).  Oral administration of polysaccharide 
extracted from R. tanguticum (RTP) for 5 days exhibited marked protective effects on oxidative 
stress and brain edema on WDIAI model of TBI in rats by reduction water content and MDA 
levels. It also resulted in enhancement SOD and Na+-K+ ATPase activity after injury (116). 
3.15. Salvia tomentosa 
Salvia tomentosa (S. tomentosa), belongs to the Lamiaceae family. It has used in traditional 
Chinese medicine to manage various conditions including stomatitis, glossitis, gingivitis, 
pharyngitis, flatulent dyspepsia, galactorrhea and hyperhydrosis (117). The major components of 
the essential oil from S. tomentosa includes β-pinene, α-pinene, trans-pinocarveol, myrtenol, 
caryphyllene oxide and d-camphor (118). The reported effects of this herb include antioxidant 
(119), antibacterial (120) and anticancer (121) activities. 
The effect of luteolin which is a flavone isolated from the aromatic flowering plant of S. 
tomentosa on CCI model of TBI in mice showed that it significantly reduced levels of TNFα and 
IL-1β in blood and brain tissue of mice (122). 
3.16. Nigella sativa 
Nigella sativa (N. sativa), is a grassy plant from the Ranunculaceae family which grows in cold 
and temperate climates. The seeds of N. sativa contain thymoquinone and monoterpenes 
including p-cymene, a-pinene (123), nigellidine (124), nigellimine (125) and a saponin (126). 
The seeds have different pharmacological effects including anti-asthmatic, anti-dyspnea (127), 
anti-nociceptive, anti-diabetes, antihypertensive  (128), anti-inﬂammatory, immunomodulatory 
(129), anticonvulsant (130), anxiolytic (131) and anti-nociceptive effects (132). 
It has been shown that N. sativa improved neurological functions and reduced the infarct volume 
in middle cerebral artery-occluded rats  (133). Treatment with thymoquinone (TQ) orally for one 
week after the induction TBI by WDIAI model in mice reduced activity of lactate dehydrogenase 
(LDH) and plasma copeptin level in the brain tissue (134). 
3.17. Dracaena cochinchinensis 
Dracaena cochinchinensis (D. cochinchinenesis), belongs to the Asparagaceae family and is  
widely cultivated in different provinces of China. The main components of D. cochinchinenesis 
are flavonoids, terpenes, steroids, saponins and phenols (135). Resina Draconis (RD) which is a 
resin obtained from D. cochinchinensis, is a popular traditional Chinese medicine widely used 
for the management of various conditions including cerebral arterial thrombosis, ischemic heart 
disease (136), trauma and allergic dermatitis (137, 138). Several therapeutic effects for RD has 
been described including its anti-tumor (139), anti-diabetes (140), analgesic, anti-inflammatory 
(141) and immunomodulatory (142) activities. 
Administration RD aqueous extract intra-peritoneally for 5 days after the induction TBI by 
WDIAI model in rat reduced serum levels of MDA, IL-1β, TNF-α and IL-6. It also reduced the 
amount of neuronal cell apoptosis in brain tissue as well as increased the serum SOD activity 
(143). 
3.18. Polygoni Cuspidati 
Polygoni Cuspidati (P. Cuspidati), also known as Huzhang in Chinese belongs to the 
Polygonaceae family. It has been used as a traditional Chinese medicine for the management of 
inflammatory conditions, infections, jaundice, skin burns and hyperlipidemia (144). The reported  
therapeutic effects include anti-inﬂammatory (145), analgesic, antibacterial, antiviral analgesic 
(146), immunomodulatory (147), and anticancer (148) activities. The major compounds of P. 
cuspidati are polydatin, resveratrol, torachryson-8-O-glucoside, and emodin (149). 
The effect of oral administration of emodin after the induction TBI by WDIAI model in rat 
significantly ameliorated brain edema after TBI, improved neurological severity score (NSS) and 
reduced BBB permeability. Emodin also inhibited the expression of aquaporins (AQPs), 
including AQP-1, AQP-4 and AQP-9, hypoxia-inducible factor-1α and matrix metalloprotein-9  
(150). Injection of resveratrol intraperitoneally after induction of TBI by WDIAI model 
remarkably improved NSS and reduced escape latency in MVM, brain edema and levels of the 
autophagy marker proteins (151). 
3.19. Rosmarinus ofﬁcinalis 
Rosmarinus ofﬁcinalis (R. ofﬁcinalis), known as rosemary, belongs to the Lamiaceae family. It 
has been shown to have different therapeutic effects including antibacterial (Huhtanen, 1980), 
anti-nociceptive, anti-inﬂammatory (Takaki et al., 2008), antioxidant (Inatani et al., 1983) and 
vascular smooth muscle relaxant properties (Aqel, 1992b). The main constituents of the essential 
oil of R. ofﬁcinalis are gamma-terpinene, p-cymene, linalool, eucalyptol, thymol, alpha-pinene 
and beta-pinene (152). 
The neuroprote  ctive effects of R. ofﬁcinalis in the transient model of focal cerebral 
ischemia have shown to be related to its ability to decrease sub-cortical and cortical infarct 
volumes, NSS, cerebral edema and BBB permeability (153).  Oral administration of R. ofﬁcinalis 
after induction of TBI by LFP model reduced the latency to find platform and increased time 
spent in target quadrant in MWM. Additionally, it reduced neuronal degeneration and glial 
fibrillary acidic protein (GFAP)-positive cells. It also reduced the levels of TNF-α, IL-1β and IL-
6 in hippocampus and increased activity of glutathione peroxidase (GPx), SOD and CAT (154). 
3.20. Centella asiatica 
Centella asiatica (C. asiatica), is a perennial plant belonging to the Umbellifere family (155). 
The main components of C. asiatica are saponins, brahmoside, brahminoside, glycosides 
isothankuniside, hankuniside, sterols and flavonoids (156). This plant has been shown to have 
several pharmacological effects  including  anti-inﬂammatory (157), wound healing (158), 
sedative, anxiolytic (159), antidepressant (160), anticonvulsant (161) and antioxidant (162) 
activities. 
C. asiatica  when administered orally improved memory and learning flexibility deficits and 
ameliorated neuronal damage in the dorsal hippocampus when mild chronic cerebral 
hypoperfusion was induced by right common carotid artery occlusion in rats (163).  It has also 
been shown after the induction TBI by WDIAI model in rat, administration of C. asiatica 
hydroethanolic extract intra-peritoneally increased the activation of Krox-20, the expression of 
neuregulin-1 (NRG-1) and the distribution of phospholipids and improved neurological functions 
(164). 
3.21. Curcuma longa 
Curcuma longa (C. longa), commonly known as turmeric belongs to the family of 
Zingiberaceae. It’s applied in Ayurvedic medicine for treatment of inflammatory diseases for a 
long time. This plant has been shown several therapeutic actions including anti-asthmatic (165), 
oxidant (166), immunomodulatory and anti-inflammatory (167) activities. 
The effect of curcumin when evaluated after the induction TBI by FPI model in rat showed that 
it improved the memory retention  and learning ability in MVM test, reduced oxidative stress, 
increased BDNF levels, as well as, protected synaptic proteins and mitochondria (168-171). 
Treatment with curcumin intra-peritoneally before the induction TBI by WDIAI model in rat 
reduced the cerebral damage and brain levels of MDA. It also improved various neurological 
functions in the rotarod and inclined-plane test (172). In addition, administration of curcumin 
before TBI and 30 min after TBI, reduced cerebral edema, AQP4 expression within the 
pericontusional cortex, NF-κB activation and IL-1β expression. It also improved neurological 
function in rotarod and open-ﬁeld test in the CCI induced TBI in mice (173). In a similar study 
assessing the preventive effect of curcumin after the induction TBI by WDIAI model in mice 
showed that curcumin reduced TNF-α, MCP-1, IL-1β, IL-6, and RANTES (regulated on 
activation, normal T cell expressed and secreted), TLR4 expression, neuronal and apoptotic cell 
death. It also reduced microglial activation and improved NSS (174). 
3.22. Curcuma zedoaria 
Curcuma zedoaria (C. zedoaria), known as zedoary and white turmeric belongs to the 
Zingiberaceae family. The main ingredients of the essential oil of C. zedoaria are curzerenone, 
germacrone, curdione, 1,8-cineole, cumene, a-phellandrene, ß-turmerone, ß-elemene, 1,8-cineole 
and zingiberene (175). Different therapeutic effects including anti-peptic ulcer (176), anti-
inflammatort, antinociceptive (177), antioxidant (178) and  anticancer (179). 
The effect of curdione after the induction middle cerebral artery occlusion surgery by cerebral 
ischemia–reperfusion model in rat showed curdione reduced the NSS and infarct size.  It also  
improved cognitive function and neuronal morphologic damages. In addition, it decreased MDA 
content and enhanced the activities of GSH-PX , CAT and SOD (180). Treatment with β-
elemene after the induction TBI by WDIAI model in rat was improved NSS, reduced TNF-α, IL-
1ß, apoptosis index and expression of Toll-like receptor (TLR4) and casepase 3. It also increased 
the expression of IkB (inhibitor of kB) (181). 
3.23. Salvia Militorrhiza 
Salvia Militorrhiza (S. Militorrhiza), commonly known as red sage or Chinese sage belongs to 
the Lamiaceae family. It is used in traditional medicine for prevention and treatment of various 
cardiovascular diseases such as stroke and myocardial infarction (182). The chemical 
composition of S. Militorrhiza are tanshinone I, tanshinone IIA, salvianolic acid (or salvianolic 
acid B) and dihydrotanshinone (183).  
Injection of salvianolic acid B (SalB) intra-peritoneally after the induction of TBI by CCI model 
remarkably reduced brain water content, lesion volume, Iba-1, (an activated microglia marker), 
IL-1β and TNF-α. It also increased TGF-β1 and IL-10 as well as improved neurological function 
in wire-grip and MVM test (184). 
3.24. Satureja khuzistanica 
Satureja khuzistanica (S. khuzistanica) or jamzad, is a herb belonging to the Lamiaceae family. 
The major constituents of S. khuzistanica are p-cymene, carvacrol, and γ-terpinene (185). In folk 
medicine, S. khuzistanica is used as an analgesic and antiseptic (186). Several therapeutic effects 
for saffron including antidiarrhea and antispasmodic (187), anti-inflammatory, anti-nociceptive 
(188) and antioxidant (189) have been described. 
It has been shown that after the induction TBI by WDIAI model in rat, administration of S. 
khuzistanica essential oil intra-peritonieally ameliorated veterinary coma scale (VCS) scores, 
damage to BBB and brain edema. There was a reduction in IL-6, IL-1ß  and TNF-a levels. There 
was also a reduction in intracranial pressure, BBB permeability and neuronal death and increased 
IL-10 level and numbers of viable astrocytes in the treated groups (190). 
3.25. Scutellaria baicalensis 
Scutellaria baicalensis (S. baicalensis), is a plant belonging to the Lamiaceae family. S. 
baicalensis has been used in traditional medicine for managing various inflammatory conditions, 
hypertension and cardiovascular diseases (191). 
Treatment with baicalin (a major bioactive compound of S. baicalensis) after the induction TBI 
by CCI model in rat model reduced the number of degenerating neurons in FJB staining, 
contusion volume of brain, mRNA and protein expression of IL-1β, IL-6 and TNF-α. It also 
improved neurological functions in rotarod, tactile adhesive removal and beam walk test (192). 
3.26. Drynaria fortune 
Drynaria fortune (D. fortune), or gu-sui-bu, is a fern of the Polypodiaceae family. D. fortune has 
been used in traditional medicine for the treatment of various bone conditions (193).  
Effect of Rhizoma drynariae (R. drynariae) aqueous extract from the dried roots of D. fortune 
after the induction TBI by WDIAI model in rat showed R. drynariae signiﬁcantly reduced the 
level of CD8 T cells without affecting the levels of IL-2 and CD4 cells (194). Administration of 
R. drynariae aqueous extract orally significantly reduced the brain lesion volume and blood 
levels of IL-6. It also ameliorated anxiety and depression-like behaviors, improved cognitive 
function and NSS. In addition, in the CCI model of TBI in rats it increased blood monocyte 
numbers, IL-10 and the percentage of blood CD3 and CD4 T lymphocytes. It also inhibited 
macrophage and microglial activation (195). 
Molecular mechanisms underlying the neuroprotective effects on TBI 
It was shown the therapeutic effect of medicinal plants on TBI are mainly mediated by anti-
inflammatory, anti-oxidant and immunomodulatory mechanisms. We have reviewed the main 
molecular mechanisms related to these effects in this section. 
The protective effect of formononetin on neurobehavioral disorders after or before TBI may be 
associated with its inhibition of pro-inﬂammatory cytokines and oxidative stress as well as 
activation of Nrf2-dependent antioxidant pathways (13, 14). It has been shown hydroethanolic 
extract of A. melegueta on TBI normalized the genes that are implicated in the chemokine, 
cytokine, oxidative stress and NF-κB signaling pathways induced by TBI (26). Protective effect 
of allicin on TBI is potentially associated with its anti-oxidative  and anti-inflammatory 
properties through Akt/eNOS pathway (32). The protective effects of artesunate in TBI also 
occur through inhibition of pro-inﬂammatory cytokines and apoptosis process by reducing the 
Bax expression and increasing Bcl2 expression, as well as modulation of various neurotrophic 
factors (44).  
When the the antioxidant effect of C. tinctorius was studies, it was shown that HSYA by 
reduction of oxidant markers and enhancement antioxidant markers could be a potential 
neuroprotective medication in cases of TBI (53). In a CI model of TBI, it was shown that 
cinnamon could be play an important role in reducing of infarct and edema formation through 
modulation of Nfr2 and cytokine expression. It also reduce oxidative stress and could exert 
neuroprotective activity through these mechanisms  (65). The protective effect of osthole on TBI 
may be associated with its antiapoptotic and antioxidative activities (70). 
Crocin has also shown to inhibit the production of the pro-inﬂammatory cytokines and 
suppresses Notch signaling activation (78). In a CCI model of TBI, it was shown that DCXF 
aqueous extract improved the proliferation of neural stem cells and reduced the BBB damage as 
well brain edema. It also alleviated the neuronal loss and improvement in neurological functions 
including learning, memory and motor abilities mainly through inhibition of inﬂammation 
process (81). The protective effect of breviscapine on neurobehavioral disorders after TBI may 
be associated with its mechanism of improving energy metabolism, free radical scavenging, 
inhibition of intracellular Ca 2+, overload, excitatory amino acid toxicity, inflammatory 
suppression, regulation of brain blood vessel activity, and suppression of IL-6 expression (87, 
196, 197). The protective effect of G. elata on TBI could be associated to the reduction of 
proinﬂammatory cytokines, inﬂammation and astrocytes accumulation (94). Treatment with M. 
sylvestris prevented neurodegeneration after TBI by reducing astrocytosis, pro-inﬂammatory 
cytokines and oxidative stress in the brain tissue (96). 
The potential therapeutic effects of P. ginseng could be due to inhibition of inﬂammatory 
mediators, reactive oxygen species (ROS) production and microglial activation (107). 
Ginsenosides has been shown to protect neurons from ischemic damage and rescue hippocampal 
neurons from ischemic damage by free radicals scavenging (108). GTS administration after TBI 
has been shown to reduce the secondary injury by reduction of oxidative and nitrative stress as 
well as attenuating the expression of proinﬂammatory cytokines and apoptotic cell death (109). 
The protective effect of GTS on neurobehavioral disorders after TBI was related to the regulation 
of nerve growth-related factors expression and improvement of neural stem/progenitor cells 
proliferation (110). The underlying mechanisms of GTS on TBI induced modified Feeney's 
method could be potentially mediated through various mechanisms including reducing MDA 
level, expression of TNF-α and IL-1β, generation of reactive oxygen species (ROS), elevating 
the activity of SOD and inflammatory reactions (111). The R. tanguticum have been shown to 
have neuroprotective effects on TBI through by inhibiting oxidative stress (114-116). 
The potential mechanism for protective effects of luteolin could be due to the inhibition of 
release of inflammatory cytokines (122). The possible mechanisms of TQ on TBI are by 
improving the redox balance, abating the inflammatory cytokines, and restoring the balance 
between apoptotic and anti-apoptotic factors (134). 
Another study demonstrated the antioxidant and anti-inflammatory effects of R. draconis 
aqueous extract through its effect on SOD, MDA, IL-1β, TNF-α and IL-6 levels in TBI rat (143). 
It has been shown tha emodin attenuated brain edema and BBB disruption after TBI, mediated 
via inhibition of HIF-1α/AQPs and HIF-1α/MMP-9 pathways (150). The protective effect of 
resveratrol was shown to have a protective effect on TBI by upregulation of post-synaptic density 
protein 95, synaptophysin and by suppressing neuronal autophagy (151). 
R. ofﬁcinalis, has shown to improve cognitive deficits in TBI by inhibiting inflammation and 
oxidative stress (154). C. asiatica extract has been shown to have a neuroprotective effect on TBI 
potentially by activation of Krox-20 gene thereby triggering the formation of new phospholipids 
in nerve cells (164). The proposed mechanism of curcumin on TBI includes inhibition of 
proinﬂammatory cytokines, oxidative stress, TLR4 and NF-κB pathway (168-174). β-elemene 
had a protective effect on TBI which is most likely mediated via reducing the  caspase-3 enzyme 
activity, expression of TLR4 and inflammatory cytokines (181). The neuroprotective effect of 
SalB against TBI was associated with its anti-inflammatory activities (184). R. drynariae has 
been shown to have a protective role in TBI-induced brain damage, potentially mediated by its 
immune-promoting, anti-inflammatory and neuroprotective effects (194, 195). In a WDIAI 
model of TBI, S. khuzistanica has been shown to play a crucial role in reducing edema formation  
and infarct through its anti-inflammatory action and by reducing neuronal loss (190). The 
neuroprotective effect of baicalein in TBI-induced brain injury could be potentially mediated via 
inhibition pro-inﬂammatory cytokines (192). 
Conclusion 
This review summarized the growing evidence on the protective effects of medicinal plants and 
their constituents on TBI. Although these studies were mostly conducted in animal models of 
TBI, potentially similar effects could be expected in human TBI patients. This shows that natural 
compounds have great therapeutic potential for reducing neurodegeneration and improving 
functional outcome in TBI patients. However, further studies are required to establish the clinical 
effects of medicinal plants and their extracts on TBI and their molecular mechanisms.   
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Table 1: The summary of animal models 7 
Animal model description 
Fluid percussion 
injury (FPI)  models 
The fluid pressure pulse insult is caused by a pendulum striking the piston of a 
reservoir of fluid to the intact dura through a craniotomy, which is made either 
centrally around the midline, or laterally over the parietal bone, between 
bregma and lambda. Brief displacement and deformation of brain tissue 
produce following the percussion, and the severity of injury depends on the 
strength of the pressure pulse. 
 
Cortical impact injury 
(CCI) model 
The exposed intact dura will be under effect of pneumatic or electromagnetic 
impact device to create a rigid impactor. This method can mimic cortical tissue 
loss, acute subdural hematoma, axonal injury, concussion, blood–brain barrier 
(BBB) dysfunction and even coma. 
 
Penetrating ballistic-
like brain injury 
(PBBI) 
A temporary cavity in the brain is produced by transmission of projectiles with 
high energy and a leading shockwave. The projectile’s anatomical path and 
degree of energy transfer can effect on the outcome in this model.  
 
 
Weight drop models After exposing the skull (with or without a craniotomy), a falling weight 
guided to it. Injury severity in these models can be altered by adjusting the 
mass of the weight and the height from which it falls. This model also divided 
to some subdivisions such as Feeney’s weight-drop model and Marmarou 
model. 
 
 Table 2. Summary of studies reporting the effects of medicinal plants on TBI. 
Plant 
 
Ext./Cons. Dose Exp. 
model 
Effect Ref. 
A. racemosa 
 
Formononetin 10 and 30 mg/kg WDIAI Improved NSS score 
Increased cortical neuronal numbers and IL-10 
Decreased IL-6 and TNF-α  
13 
Formononetin 10 and 30 mg/kg WDIAI Improved NSS score 
Reduced brain edema and inhibited neuronal apoptosis 
Up-regulated the expression levels of miR-155 and HO-
1 and down-regulated the protein expression of BACH1 
14 
A. melegueta seed AEE 10, 100, 250, 500 
and 1000 mg/kg 
FPI Reduced neuronal injury and microglial activation 
 
26 
A. sativum Allicin 1, 10 and 50 
mg/kg 
CCI Reduced contusion volume, water content, Bcl-2/Bax 
ratio, MDA, protein carbonyl, TNF-α and IL-1β 
Increased CAT, SOD, GST, IL-10, TGF-β1, Akt and 
Enos 
Inhibited the activation of caspase-3 and PARP 
 
A. annua Atesunate 30 mg/kg CCI Reduced tissue damage and inﬂammation, expression of 
Il-1ß, TNF-α, iNOS, BDNF, VEGF, GDNF and 
inﬂammasomes components (NLRP3, ASC and 
Caspase-1) 
44 
C. tinctorius  HSYA 10 and 30 mg/kg CCI Increased the SOD, CAT, GSH and GSH/ GSSG ratio  
Decreased the MDA and GSSG 
53 
C. zeylanicum polyphenol E 10 mg/kg CI Reduced infarct and edema formation suppressing the 
expression of NF-κB, IL-1, IL-6, GFAP, NCAM and 
Nrf2 
65 
C. monnieri Osthole 10, 20 and 40 WDIAI Reduced neurological deficits, cerebral edema and 70 
mg/kg hippocampal neuron loss  
Increased SOD, GSH MDA, Bcl-2/Bax, the expression 
of active caspase-3, and the number of apoptotic cells 
C. sativus Crocin 20 mg/kg CCI Activated the Notch signaling pathway  
Reduced microglial activation, cell apoptosis, and 
release of IL-1β and TNF-α  
Improved NSS and brain edema 
78 
DCXF AE 520.6 and 2603.0 
mg/kg 
CCI Improved behavioral tests 
Reduced BBB permeability, brain edema, microglia and 
astrocyte activation, and neurons loss 
81 
E. breviscapus Breviscapine 75 μg CCI Improved NSS score  
Reduced expression of IL-6 in the injured cortex and IL-
6-positive cell number in injured brain tissue 
87 
G. elata AE 505 and 1515 
mg/kg 
 Improved locomotor functions  
Reduced the number of astrocyte and the expression of 
IL-6 and TNF-α  
94 
P. ginseng AE 50, 100 and 200 
mg/kg 
WDIAI Improved neurological deficits  
Reduced levels of MDA, nitrite, AChE, TNF-a and IL-6 
Increased GSH, SOD and CAT 
107 
GTS 100 and 200 
mg/kg 
CCI Reduced neuronal loss in hippocampal regions of CA1, 
CA2, and CA3, contusion volume and percentage of 
contusion 
Improved neurological deficits 
108 
 GTS (5, 10, 20, 40, 60 
and 80 mg/kg, 
i.p.) 
 Improved NSS score  
Reduced brain water content, neuronal loss, levels of 
MDA, NOSs and NO, apoptotic cell death, expression 
of caspase-3, bax and Bcl-2 
Increased the activity of SOD 
109 
Down-regulated IL-1β, IL-6, and TNF-α and 
upregulated IL-10 
 GTS (5, 10, 20, 40, 60 
and 80 mg/kg, 
i.p.) 
 Improved NSS score  
Increased the expression of NGF, GDNF and NCAM 
Inhibited the expression of Nogo-A, Nogo-B, TN-C, and 
the number of BrdU/nestin positive NSCs in the 
hippocampal formation 
110 
 GTS (10, 20, 40, 60 
and 80 mg/kg, 
i.p.) 
 Improved neurological function and histological 
morphology of brain tissue 
112 
M. sylvestris  250 and 500 
mg/kg 
CCI Improved cognitive function in MVM test  
Reduced neuronal loss, GFAP positive cells, ROS 
production and levels of LPO, IL-1β, IL-6, and TNF-α  
Increased SOD level  
96 
R. tanguticum AE 3, 6 and 12 
mg/kg 
CCI Ameliorated BBB damage and brain edema 
Increased SOD, CAT, GSH, and  GSH/GSSG ratio 
Decreased the MDA and GSSG levels 
114,115 
Polysaccharide 100, 200 and 400 
mg/kg 
WDIAI Reduced water content and MDA levels 
Increased SOD and Na+-K+ ATPase activity 
116 
S. tomentosa Luteolin 20 mg/kg CCI Reduced levels of TNFα and IL-1β in blood and brain 
tissue 
122 
N. sativa TQ 10 mg/kg WDIAI Reduced activity of LDH and plasma copeptin level in 
brain tissue 
134 
D. cochinchinenesis AE 40 and 80 mg/kg WDIAI Reduced serum levels of MDA, IL-1β, TNF-α and IL-6, 
and the amount of neuronal cell apoptosis in brain tissue 
Increased serum SOD activity 
143 
P. cuspidati Emodin 10 mg/kg WDIAI Improved NSS 
Reduced BBB permeability, ameliorated brain edema  
150 
Inhibited the expression of AQP-1, AQP-4 and AQP-9, 
HIF-1α and MMP-9 
Resveratrol 100 mg/kg WDIAI Improved NSS  
Reduced escape latency, brain edema, levels of the 
autophagic marker proteins, microtubule-associated 
protein light chain 3-II and Beclin1 in the hippocampus 
151 
R. ofﬁcinalis AE 40, 80 and 160 
mg/ml 
LFP Decreased latency to find platform, neuronal 
degeneration and GFAP-positive cells, ROS generation, 
levels of IL-1β, IL-6 and TNF-α  
Increased time spent in target quadrant and activity of 
SOD, GPx and CAT 
154 
C. asiatica AEE 90 mg/kg WDIAI Increased the activation of Krox-20, the expression of 
NRG-1, and the distribution of phospholipids 
Improved neurological deficits 
164 
C. longa Curcumin 500 ppm FPI Improved cognitive function in MVM test  
Reduced oxidative stress  
Increased BDNF levels 
Protected synaptic proteins and mitochondria 
168-171 
Curcumin 50, 100 and 200 
mg/kg 
WDIAI Reduced IL-1β, IL-6, TNF-α, MCP-1 and RANTES, 
TLR4 expression, neuronal and apoptotic cell death and 
microglial activation  
Improved NSS 
174 
Curcumin 75, 150 and 300 
mg/kg 
CCI Reduced cerebral edema, AQP4 expression, NF-κB 
activation and IL-1β expression  
Improved neurological function 
173 
Curcumin 50 and 100 
mg/kg 
WDIAI Reduced cerebral damage and brain levels of MDA 
Improved neurological functions  
172 
C. zedoaria β-elemene 100 mg/kg WDIAI Improved NSS 
Reduced TNF-α, IL-1ß, TUNEL positive cells, 
apoptosis index and expression of TLR4 and casepase 3 
Increased expression of IkB  
181 
D. fortune AE 45±0.05 ml/rat WDIAI Reduced the level of CD8 T cells 
No effect on  IL-2 and CD4 levels  
194 
AE 20 mg/kg CCI Decreased brain lesion volume, IL-6 
Improved NSS and cognitive function 
Increased IL-10, blood monocyte numbers and 
percentage of blood CD3 and CD4 T lymphocytes 
Inhibited microglial/macrophage activation 
195 
S. Militorrhiza SalB 25 mg/kg CCI Reduced brain water content, lesion volume, PMN, Iba-
1, TNF-α and IL-1β 
Increased IL-10 and TGF-β1  
Improved neurological function  
184 
S. khuzistanica EO 50, 100 and 200 
mg/kg 
WDIAI Ameliorated brain edema, damage to BBB and 
veterinary coma scale (VCS) scores  
Reduced levels of TNF-a, IL-1ß, IL-6, intracranial 
pressure, neuronal death and BBB permeability 
Increased IL-10 level and numbers of viable astrocytes 
190 
S. baicalensis Baicalein 30 mg/kg CCI Reduced the number of degenerating neurons, contusion 
volume, mRNA and protein expression of TNF-α, IL-1β 
and IL-6  
Improved neurological functions  
192 
 
Abbreviations: TBI.: Traumatic brain injury, Exp.: Experimental, Ref.: Reference, Ext.: Extract, Conc.: 
Concentration, EO.: Essential oil, AE.: Aqueous extract, AEE.: Aqueous ethanolic extract, FPI.: Fluid percussion 
injury, HSYA.: Hydroxysafflor yellow A, CCI.: Cortical impact injury, miR-155.: microRNA-155, HO-1.: heme 
oxygenase 1, BDNF.: Brain-derived neurotrophic factor, VEGF.: Vascular endothelial growth factor, GDNF.: Glial 
cell line-derived neurotrophic factor, SOD.: Superoxide dismutase , AChE.: Acetylcholinesterase, NOSs.: Nitric 
oxide synthases , NO.: nitric oxide, CAT.: Catalase, GSH.:  Glutathione, GSH/GSSG.: Glutathione /Glutathione 
disulfide, MDA.: Malondialdehyde, CI.: Cold injury, NF-Κβ.: Nuclear factor kappa B, GFAP.: Glial fibrillary acidic 
protein, NCAM.: Neuronal cell adhesion molecule, Nrf2.: Nuclear factor erythroid 2-related factor 2, IL-1β.: 
Interleukin-1β  , TNF-α.: Tumor necrosis factor-α, NSS.: Neurological severity score, BBB.: Blood brain barrier , 
GTS.: Ginseng total saponins, WDIAI.: Weight drop–impact acceleration injury, TQ.: Thymoquinone, LDH.: 
Lactate dehydrogenase,  AQP-1.: Aquaporin-1 , HIF-1α.: , Hypoxia-inducible factor-1α  MMP-9.: Matrix 
metalloprotein-9 ,  LFP.: Lateral fluid percussion, ROS.: Reactive oxygen species, GPx.: Glutathione Peroxidase, 
NRG-1.: Neuregulin-1, TUNEL.: Terminal deoxynucleotidyl transferase dUTP nick end labeling, TLR4.: Toll-like 
receptor4, IkB.: Inhibitor of kB, Bcl-2.: B-cell lymphoma 2, NGF.: nerve growth factor, GDNF.: Glial cell line-
derived neurotrophic factor, NCAM .: Neural cell adhesion molecule, Nogo-A.: Neurite outgrowth inhibitor A, TN-
C.: Tenascin-C, BrdU.: 5-Bromo-2ʹ-deoxy-uridine, NSCs.: Neural stem/progenitor cells, RANTES.: Regulated on 
activation, normal T cell expressed and secreted, TGF-β1.: Transforming growth factor beta 1, SalB.: Salvianolic 
acid B.  
Figure 1. Neuroprotective effects of medicinal plants on TBI. 
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 Figure 2. Possible mechanisms of action of medicinal plants on TBI. 
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